Objectives: Evaluation of the performance of the EMIT 2000 Tacrolimus assay on the Abbott Architect c8000 analyzer.
Design And Methods: Imprecision studies were performed and patient samples were assayed by EMIT assay and by LC-MS/MS.
Results: Limit of quantification was established at 2.8 microg/L. A positive bias of 17.5% between results measured on EMIT and on LC-MS/MS was detected.
Conclusions: EMIT 2000 Tacrolimus assay is suitable for automated analyses of Tacrolimus on the Architect c8000.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.clinbiochem.2006.06.011 | DOI Listing |
Publication Analysis
Top Keywords
emit 2000
12
2000 tacrolimus
12
tacrolimus assay
12
architect c8000
12
assay abbott
8
abbott architect
8
application emit
4
tacrolimus
4
assay
4
c8000 high
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!